Altered tau expression profiles are associated with several neurological diseases like e.g., Alzheimer’s Disease (AD) and Fronto-temporal dementia (FTD), causing axonal transport perturbations early in disease progression [13,14]. Here, MAPT is linked to frontotemporal dementia.